China Endometriosis Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Endometriosis Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Endometriosis Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Endometriosis Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Debiopharm Group

    • Astellas Pharma

    • ObsEva

    • Roivant Sciences GmbH

    • Takeda Pharmaceutical Company Limited

    • Repros Therapeutics

    • Pfizer

    • Neurocrine Biosciences

    • AbbVie

    • AstraZeneca

    • ValiRx

    • Evotec AG

    • Kissei Pharmaceutical

    By Type:

    • Hormonal Therapy

    • Add-back Medication

    • Progestogens

    • Chinese Herbs

    By End-User:

    • Hospitals

    • Clinics

    • Research Institutes

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Endometriosis Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Endometriosis Drugs Market Size and Growth Rate of Hormonal Therapy from 2016 to 2027

    • 1.3.2 China Endometriosis Drugs Market Size and Growth Rate of Add-back Medication from 2016 to 2027

    • 1.3.3 China Endometriosis Drugs Market Size and Growth Rate of Progestogens from 2016 to 2027

    • 1.3.4 China Endometriosis Drugs Market Size and Growth Rate of Chinese Herbs from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Endometriosis Drugs Market Size and Growth Rate of Hospitals from 2016 to 2027

    • 1.4.2 China Endometriosis Drugs Market Size and Growth Rate of Clinics from 2016 to 2027

    • 1.4.3 China Endometriosis Drugs Market Size and Growth Rate of Research Institutes from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Endometriosis Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Endometriosis Drugs by Major Types

    • 3.4.1 Market Size and Growth Rate of Hormonal Therapy

    • 3.4.2 Market Size and Growth Rate of Add-back Medication

    • 3.4.3 Market Size and Growth Rate of Progestogens

    • 3.4.4 Market Size and Growth Rate of Chinese Herbs

    4 Segmentation of Endometriosis Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Endometriosis Drugs by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Endometriosis Drugs in Hospitals

    • 4.4.2 Market Size and Growth Rate of Endometriosis Drugs in Clinics

    • 4.4.3 Market Size and Growth Rate of Endometriosis Drugs in Research Institutes

    5 Market Analysis by Regions

    • 5.1 China Endometriosis Drugs Production Analysis by Regions

    • 5.2 China Endometriosis Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Endometriosis Drugs Landscape Analysis

    • 6.1 North China Endometriosis Drugs Landscape Analysis by Major Types

    • 6.2 North China Endometriosis Drugs Landscape Analysis by Major End-Users

    7 Central China Endometriosis Drugs Landscape Analysis

    • 7.1 Central China Endometriosis Drugs Landscape Analysis by Major Types

    • 7.2 Central China Endometriosis Drugs Landscape Analysis by Major End-Users

    8 South China Endometriosis Drugs Landscape Analysis

    • 8.1 South China Endometriosis Drugs Landscape Analysis by Major Types

    • 8.2 South China Endometriosis Drugs Landscape Analysis by Major End-Users

    9 East China Endometriosis Drugs Landscape Analysis

    • 9.1 East China Endometriosis Drugs Landscape Analysis by Major Types

    • 9.2 East China Endometriosis Drugs Landscape Analysis by Major End-Users

    10 Northeast China Endometriosis Drugs Landscape Analysis

    • 10.1 Northeast China Endometriosis Drugs Landscape Analysis by Major Types

    • 10.2 Northeast China Endometriosis Drugs Landscape Analysis by Major End-Users

    11 Southwest China Endometriosis Drugs Landscape Analysis

    • 11.1 Southwest China Endometriosis Drugs Landscape Analysis by Major Types

    • 11.2 Southwest China Endometriosis Drugs Landscape Analysis by Major End-Users

    12 Northwest China Endometriosis Drugs Landscape Analysis

    • 12.1 Northwest China Endometriosis Drugs Landscape Analysis by Major Types

    • 12.2 Northwest China Endometriosis Drugs Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Debiopharm Group

      • 13.1.1 Debiopharm Group Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Astellas Pharma

      • 13.2.1 Astellas Pharma Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 ObsEva

      • 13.3.1 ObsEva Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Roivant Sciences GmbH

      • 13.4.1 Roivant Sciences GmbH Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Takeda Pharmaceutical Company Limited

      • 13.5.1 Takeda Pharmaceutical Company Limited Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Repros Therapeutics

      • 13.6.1 Repros Therapeutics Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Pfizer

      • 13.7.1 Pfizer Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Neurocrine Biosciences

      • 13.8.1 Neurocrine Biosciences Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 AbbVie

      • 13.9.1 AbbVie Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 AstraZeneca

      • 13.10.1 AstraZeneca Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 ValiRx

      • 13.11.1 ValiRx Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Evotec AG

      • 13.12.1 Evotec AG Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 Kissei Pharmaceutical

      • 13.13.1 Kissei Pharmaceutical Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Endometriosis Drugs Market Size and Growth Rate of Hormonal Therapy from 2016 to 2027

    • Figure China Endometriosis Drugs Market Size and Growth Rate of Add-back Medication from 2016 to 2027

    • Figure China Endometriosis Drugs Market Size and Growth Rate of Progestogens from 2016 to 2027

    • Figure China Endometriosis Drugs Market Size and Growth Rate of Chinese Herbs from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Endometriosis Drugs Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure China Endometriosis Drugs Market Size and Growth Rate of Clinics from 2016 to 2027

    • Figure China Endometriosis Drugs Market Size and Growth Rate of Research Institutes from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Endometriosis Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Endometriosis Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Endometriosis Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of Endometriosis Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Hormonal Therapy

    • Figure Market Size and Growth Rate of Add-back Medication

    • Figure Market Size and Growth Rate of Progestogens

    • Figure Market Size and Growth Rate of Chinese Herbs

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Endometriosis Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of Endometriosis Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Research Institutes

    • Table China Endometriosis Drugs Production by Regions

    • Table China Endometriosis Drugs Production Share by Regions

    • Figure China Endometriosis Drugs Production Share by Regions in 2016

    • Figure China Endometriosis Drugs Production Share by Regions in 2021

    • Figure China Endometriosis Drugs Production Share by Regions in 2027

    • Table China Endometriosis Drugs Consumption by Regions

    • Table China Endometriosis Drugs Consumption Share by Regions

    • Figure China Endometriosis Drugs Consumption Share by Regions in 2016

    • Figure China Endometriosis Drugs Consumption Share by Regions in 2021

    • Figure China Endometriosis Drugs Consumption Share by Regions in 2027

    • Table North China Endometriosis Drugs Consumption by Types from 2016 to 2027

    • Table North China Endometriosis Drugs Consumption Share by Types from 2016 to 2027

    • Figure North China Endometriosis Drugs Consumption Share by Types in 2016

    • Figure North China Endometriosis Drugs Consumption Share by Types in 2021

    • Figure North China Endometriosis Drugs Consumption Share by Types in 2027

    • Table North China Endometriosis Drugs Consumption by End-Users from 2016 to 2027

    • Table North China Endometriosis Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure North China Endometriosis Drugs Consumption Share by End-Users in 2016

    • Figure North China Endometriosis Drugs Consumption Share by End-Users in 2021

    • Figure North China Endometriosis Drugs Consumption Share by End-Users in 2027

    • Table Central China Endometriosis Drugs Consumption by Types from 2016 to 2027

    • Table Central China Endometriosis Drugs Consumption Share by Types from 2016 to 2027

    • Figure Central China Endometriosis Drugs Consumption Share by Types in 2016

    • Figure Central China Endometriosis Drugs Consumption Share by Types in 2021

    • Figure Central China Endometriosis Drugs Consumption Share by Types in 2027

    • Table Central China Endometriosis Drugs Consumption by End-Users from 2016 to 2027

    • Table Central China Endometriosis Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Endometriosis Drugs Consumption Share by End-Users in 2016

    • Figure Central China Endometriosis Drugs Consumption Share by End-Users in 2021

    • Figure Central China Endometriosis Drugs Consumption Share by End-Users in 2027

    • Table South China Endometriosis Drugs Consumption by Types from 2016 to 2027

    • Table South China Endometriosis Drugs Consumption Share by Types from 2016 to 2027

    • Figure South China Endometriosis Drugs Consumption Share by Types in 2016

    • Figure South China Endometriosis Drugs Consumption Share by Types in 2021

    • Figure South China Endometriosis Drugs Consumption Share by Types in 2027

    • Table South China Endometriosis Drugs Consumption by End-Users from 2016 to 2027

    • Table South China Endometriosis Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South China Endometriosis Drugs Consumption Share by End-Users in 2016

    • Figure South China Endometriosis Drugs Consumption Share by End-Users in 2021

    • Figure South China Endometriosis Drugs Consumption Share by End-Users in 2027

    • Table East China Endometriosis Drugs Consumption by Types from 2016 to 2027

    • Table East China Endometriosis Drugs Consumption Share by Types from 2016 to 2027

    • Figure East China Endometriosis Drugs Consumption Share by Types in 2016

    • Figure East China Endometriosis Drugs Consumption Share by Types in 2021

    • Figure East China Endometriosis Drugs Consumption Share by Types in 2027

    • Table East China Endometriosis Drugs Consumption by End-Users from 2016 to 2027

    • Table East China Endometriosis Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure East China Endometriosis Drugs Consumption Share by End-Users in 2016

    • Figure East China Endometriosis Drugs Consumption Share by End-Users in 2021

    • Figure East China Endometriosis Drugs Consumption Share by End-Users in 2027

    • Table Northeast China Endometriosis Drugs Consumption by Types from 2016 to 2027

    • Table Northeast China Endometriosis Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Endometriosis Drugs Consumption Share by Types in 2016

    • Figure Northeast China Endometriosis Drugs Consumption Share by Types in 2021

    • Figure Northeast China Endometriosis Drugs Consumption Share by Types in 2027

    • Table Northeast China Endometriosis Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast China Endometriosis Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Endometriosis Drugs Consumption Share by End-Users in 2016

    • Figure Northeast China Endometriosis Drugs Consumption Share by End-Users in 2021

    • Figure Northeast China Endometriosis Drugs Consumption Share by End-Users in 2027

    • Table Southwest China Endometriosis Drugs Consumption by Types from 2016 to 2027

    • Table Southwest China Endometriosis Drugs Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Endometriosis Drugs Consumption Share by Types in 2016

    • Figure Southwest China Endometriosis Drugs Consumption Share by Types in 2021

    • Figure Southwest China Endometriosis Drugs Consumption Share by Types in 2027

    • Table Southwest China Endometriosis Drugs Consumption by End-Users from 2016 to 2027

    • Table Southwest China Endometriosis Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Endometriosis Drugs Consumption Share by End-Users in 2016

    • Figure Southwest China Endometriosis Drugs Consumption Share by End-Users in 2021

    • Figure Southwest China Endometriosis Drugs Consumption Share by End-Users in 2027

    • Table Northwest China Endometriosis Drugs Consumption by Types from 2016 to 2027

    • Table Northwest China Endometriosis Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Endometriosis Drugs Consumption Share by Types in 2016

    • Figure Northwest China Endometriosis Drugs Consumption Share by Types in 2021

    • Figure Northwest China Endometriosis Drugs Consumption Share by Types in 2027

    • Table Northwest China Endometriosis Drugs Consumption by End-Users from 2016 to 2027

    • Table Northwest China Endometriosis Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Endometriosis Drugs Consumption Share by End-Users in 2016

    • Figure Northwest China Endometriosis Drugs Consumption Share by End-Users in 2021

    • Figure Northwest China Endometriosis Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Debiopharm Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Debiopharm Group

    • Figure Sales and Growth Rate Analysis of Debiopharm Group

    • Figure Revenue and Market Share Analysis of Debiopharm Group

    • Table Product and Service Introduction of Debiopharm Group

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma

    • Table Company Profile and Development Status of ObsEva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ObsEva

    • Figure Sales and Growth Rate Analysis of ObsEva

    • Figure Revenue and Market Share Analysis of ObsEva

    • Table Product and Service Introduction of ObsEva

    • Table Company Profile and Development Status of Roivant Sciences GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roivant Sciences GmbH

    • Figure Sales and Growth Rate Analysis of Roivant Sciences GmbH

    • Figure Revenue and Market Share Analysis of Roivant Sciences GmbH

    • Table Product and Service Introduction of Roivant Sciences GmbH

    • Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited

    • Table Product and Service Introduction of Takeda Pharmaceutical Company Limited

    • Table Company Profile and Development Status of Repros Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Repros Therapeutics

    • Figure Sales and Growth Rate Analysis of Repros Therapeutics

    • Figure Revenue and Market Share Analysis of Repros Therapeutics

    • Table Product and Service Introduction of Repros Therapeutics

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Neurocrine Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neurocrine Biosciences

    • Figure Sales and Growth Rate Analysis of Neurocrine Biosciences

    • Figure Revenue and Market Share Analysis of Neurocrine Biosciences

    • Table Product and Service Introduction of Neurocrine Biosciences

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of ValiRx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ValiRx

    • Figure Sales and Growth Rate Analysis of ValiRx

    • Figure Revenue and Market Share Analysis of ValiRx

    • Table Product and Service Introduction of ValiRx

    • Table Company Profile and Development Status of Evotec AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Evotec AG

    • Figure Sales and Growth Rate Analysis of Evotec AG

    • Figure Revenue and Market Share Analysis of Evotec AG

    • Table Product and Service Introduction of Evotec AG

    • Table Company Profile and Development Status of Kissei Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kissei Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Kissei Pharmaceutical

    • Figure Revenue and Market Share Analysis of Kissei Pharmaceutical

    • Table Product and Service Introduction of Kissei Pharmaceutical


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.